Article

Pharmacy Quiz: Test Your Knowledge on Breast Cancer

Author(s):

Saro Arakelians, PharmD

Ten quiz questions to assess your knowledge on common symptoms and treatments for breast cancer.

True or false: After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States and can occur in both men and women, but it is far more common in women.


Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Image credit: Dr_Microbe | stock.adobe.com
Related Content
Scan of breast cancer -- Image credit: Science RF | stock.adobe.com
June 5th 2025

ASCO 2025: Camizestrant With CDK4/6 Inhibitor Improves PFS in Patients With HR+/HER2- Advanced Breast Cancer

Gillian McGovern, Associate Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Study: Maternal Asthma Increases Incidence of Adverse Perinatal Outcomes
June 5th 2025

Study: Maternal Asthma Increases Incidence of Adverse Perinatal Outcomes

Savannah Callahan, PharmD Candidate
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
3D illustration of Streptococcus pneumoniae bacteria, highlighting its Gram-positive structure and role in causing respiratory infections like pneumonia
June 5th 2025

Targeted Screening Tools Can Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies

Luke Halpern, Assistant Editor
ASCO 2025: Insights on NALIRIFOX Use in Metastatic Pancreatic Ductal Adenocarcinoma From the NAPOLI-3 Trial
June 5th 2025

ASCO 2025: Insights on NALIRIFOX Use in Metastatic Pancreatic Ductal Adenocarcinoma From the NAPOLI-3 Trial

Vincent Chung, MD Alana Hippensteele, Lead Editor